X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (233) 233
humans (133) 133
mycobacterium tuberculosis - drug effects (131) 131
capreomycin (121) 121
capreomycin - pharmacology (117) 117
tuberculosis (101) 101
microbiology (100) 100
antitubercular agents - pharmacology (88) 88
pharmacology & pharmacy (86) 86
microbial sensitivity tests (66) 66
mycobacterium tuberculosis - genetics (66) 66
mutation (61) 61
kanamycin (58) 58
infectious diseases (55) 55
kanamycin - pharmacology (54) 54
amikacin (52) 52
drug resistance (52) 52
drug resistance, microbial (45) 45
mycobacterium-tuberculosis (43) 43
female (41) 41
male (41) 41
mycobacterium tuberculosis - isolation & purification (41) 41
viomycin - pharmacology (40) 40
mycobacterium tuberculosis (39) 39
animals (36) 36
bacterial proteins - genetics (36) 36
mutations (35) 35
amikacin - pharmacology (34) 34
drug resistance in microorganisms (34) 34
strains (33) 33
antibiotics (32) 32
drugs (31) 31
tuberculosis, multidrug-resistant - microbiology (31) 31
adult (30) 30
genotype (30) 30
anti-bacterial agents - pharmacology (29) 29
microbial sensitivity tests - methods (29) 29
rifampin (29) 29
antitubercular agents - therapeutic use (28) 28
cross-resistance (28) 28
drug therapy (28) 28
analysis (27) 27
capreomycin - therapeutic use (27) 27
middle aged (27) 27
rifampin - pharmacology (26) 26
bacteria (25) 25
capreomycin - administration & dosage (25) 25
tuberculosis, multidrug-resistant - drug therapy (25) 25
antibiotics, antitubercular - pharmacology (24) 24
streptomycin - pharmacology (24) 24
tuberculosis, pulmonary - drug therapy (24) 24
antitubercular agents (23) 23
research (23) 23
tuberculosis - drug therapy (23) 23
drug resistance, bacterial (22) 22
drug resistance, multiple, bacterial - genetics (22) 22
isoniazid (22) 22
mycobacterium - drug effects (21) 21
genes (20) 20
drug resistance, multiple, bacterial (19) 19
ethambutol (19) 19
ethambutol - pharmacology (19) 19
ofloxacin (19) 19
pharmacology (19) 19
sensitivity and specificity (19) 19
streptomycin (19) 19
dna, bacterial - genetics (18) 18
extensively drug-resistant tuberculosis - microbiology (18) 18
genes, bacterial (18) 18
mycobacteriology and aerobic actinomycetes (18) 18
research article (18) 18
susceptibility (18) 18
administration, inhalation (17) 17
capreomycin - chemistry (17) 17
isoniazid - pharmacology (17) 17
multidisciplinary sciences (17) 17
sequence analysis, dna (17) 17
antitubercular agents - administration & dosage (16) 16
bacterial infections and mycoses (16) 16
medicine (16) 16
mice (16) 16
pyrazinamide (16) 16
resistance (16) 16
science (16) 16
tuberculosis - microbiology (16) 16
aminoglycosides (15) 15
biochemical phenomena, metabolism, and nutrition (15) 15
ofloxacin - pharmacology (15) 15
viomycin (15) 15
aminoglycosides - pharmacology (14) 14
diagnosis (14) 14
fluoroquinolones (14) 14
laboratories (14) 14
mechanisms of resistance (14) 14
particle size (14) 14
isoniazid resistance (13) 13
multidrug-resistant (13) 13
phenotype (13) 13
public health (13) 13
rifampicin (13) 13
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (243) 243
Japanese (12) 12
French (5) 5
German (5) 5
Polish (3) 3
Russian (2) 2
Chinese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Diagnostic Microbiology & Infectious Disease, ISSN 0732-8893, 2013, Volume 76, Issue 2, pp. 187 - 196
Abstract In order to characterize molecular mechanisms of first- and second-line drug resistance in Mycobacterium tuberculosis and to evaluate the use of... 
Infectious Disease | Internal Medicine | Mutations | Pan-susceptible | MDR | Mycobacterium tuberculosis | XDR | ANTITUBERCULOSIS DRUGS | ETHAMBUTOL RESISTANCE | INFECTIOUS DISEASES | KANAMYCIN | EMBB GENE | CROSS-RESISTANCE | MICROBIOLOGY | ISONIAZID RESISTANCE | CAPREOMYCIN | STREPTOMYCIN RESISTANCE | 16S RIBOSOMAL-RNA | Isoniazid - pharmacology | Ethambutol - pharmacology | Humans | Genetic Loci | Antigens, Bacterial - genetics | Mycobacterium tuberculosis - drug effects | Capreomycin - pharmacology | Pyrazinamide - pharmacology | Ofloxacin - pharmacology | DNA-Directed RNA Polymerases | Tuberculosis, Multidrug-Resistant - microbiology | Polymerase Chain Reaction | Acetyltransferases | Republic of Korea | Amidohydrolases | Pentosyltransferases - genetics | Promoter Regions, Genetic | Mycobacterium tuberculosis - classification | DNA, Bacterial - isolation & purification | Streptomycin - pharmacology | Catalase - genetics | Oxidoreductases - genetics | Bacterial Proteins - genetics | Amikacin - pharmacology | DNA Primers | Kanamycin - pharmacology | Sequence Analysis, DNA | Mycobacterium tuberculosis - isolation & purification | DNA Gyrase - genetics | Fluoroquinolones - pharmacology | Mutation | Rifampin - pharmacology | Drug Resistance, Multiple, Bacterial - genetics | Mycobacterium tuberculosis - genetics | Tuberculosis, Multidrug-Resistant - drug therapy | Drug resistance in microorganisms | Antitubercular agents | Tuberculosis | Drug therapy | Genomics | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2018, Volume 62, Issue 2
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2, pp. e55299 - e55299
Background: India with a major burden of multidrug-resistant tuberculosis (MDR-TB) does not have national level data on this hazardous disease. Since 2006,... 
MYCOBACTERIUM-TUBERCULOSIS | SYSTEM | SOUTH-AFRICA | MULTIDRUG-RESISTANT | MULTIDISCIPLINARY SCIENCES | 2ND-LINE DRUGS | XDR-TB | PREVALENCE | INDIA | Sputum - microbiology | Tuberculosis, Pulmonary - microbiology | Isoniazid - pharmacology | Prevalence | Humans | Ofloxacin - therapeutic use | Male | Tuberculosis, Pulmonary - drug therapy | Capreomycin - pharmacology | Incidence | Capreomycin - therapeutic use | Ofloxacin - pharmacology | Ethionamide - pharmacology | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Antitubercular Agents - therapeutic use | Extensively Drug-Resistant Tuberculosis - drug therapy | Ethionamide - therapeutic use | Risk Factors | Antitubercular Agents - pharmacology | India - epidemiology | Amikacin - pharmacology | Mycobacterium tuberculosis - isolation & purification | Extensively Drug-Resistant Tuberculosis - epidemiology | Amikacin - therapeutic use | Tuberculosis, Pulmonary - epidemiology | Rifampin - pharmacology | Drug resistance in microorganisms | Tuberculosis | Research | Demographic aspects | Drug therapy | Drugs | Amikacin | Sample size | Laboratories | Ethionamide | Drug resistance | Socioeconomics | Risk factors | Demographics | Genetics | Isoniazid | Public health | Socio-economic aspects | Cultures | Risk analysis | Ofloxacin | Medical screening | Resistance factors | Patients | Capreomycin | Signaling | Infectious diseases | Disease transmission | Respiratory diseases | Liquid culture | Sputum | Mutation | Rifampin | Index Medicus
Journal Article
Journal Article
Journal Article